Grace Therapeutics Inc. (GRCE) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear

Grace Therapeutics Inc.

NASDAQ: GRCE · Real-Time Price · USD
3.10
0.02 (0.65%)
At close: Sep 26, 2025, 3:59 PM
3.09
-0.16%
After-hours: Sep 26, 2025, 07:22 PM EDT

Grace Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is April - March.
Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Mar 31, 2025 Mar 31, 2024 Mar 31, 2023 Mar 31, 2022 Mar 31, 2021
Net Income
-9.57M -12.85M -42.43M -9.82M -19.68M
Depreciation & Amortization
7K 11K 124K n/a 924K
Stock-Based Compensation
730K 913K 1.81M 1.34M 1.17M
Other Working Capital
-254K -1.36M 483K -2.77M -6M
Other Non-Cash Items
-3.22M 2.71M 33.94M -5.32M 9.21M
Deferred Income Tax
-3.2M -1.83M -9.54M -648K n/a
Change in Working Capital
342K -1.28M 181K -2.79M -5.95M
Operating Cash Flow
-14.9M -12.33M -15.91M -17.23M -14.32M
Capital Expenditures
n/a -22K -17K n/a -69K
Cash Acquisitions
n/a 111K n/a n/a n/a
Purchase of Investments
-15K -6.55M -5.01M -34.93M -9.81M
Sales Maturities Of Investments
15K 6.57M 18.18M 31.41M 21K
Other Investing Acitivies
n/a n/a n/a n/a n/a
Investing Cash Flow
n/a 104K 13.15M -3.52M -9.86M
Debt Repayment
n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a 21K n/a n/a 158K
Financial Cash Flow
14.03M 7.36M 304K n/a 59.49M
Net Cash Flow
-872K -4.87M -2.46M -20.6M 36.7M
Free Cash Flow
-14.9M -12.36M -15.93M -17.23M -14.39M